Industrieën.
Pharmaceutical & Healthcare<span id="test" class="kool-class" style="color: #b4b4b4;" fs-test-element="test"></span><span id="test" class="kool-class" style="color: #f90;" fs-test-element="test">.</span>
The essential support for<span id="test" class="kool-class" style="color: #b4b4b4;" fs-test-element="test"> complex supply chain in healthcare</span><span id="test" class="kool-class" style="color: #f90;" fs-test-element="test">.</span>
Optimalisatie van Zorginkoop: Essentiële Ondersteuning voor Complexe Supply Chains
The Netherlands is not only known as one of the best healthcare systems in Europe, but also worldwide when looking at accessibility and process efficiency. It also ranks third in terms of innovation, reflecting its rapid development in biotechnology and healthcare infrastructure (Free Opp). The competitive insurance market is cited as the main reason for the progress of the Dutch healthcare sector. In addition, the Netherlands is home to innovative medicines and a large early-stage biotechnology sector.
Pharma: Competition starts at procurement
The challenges in the pharmaceutical and biotech industry have been increasing for years due to increasing cost pressure and falling margins. In our country, the high dynamics in this internationally highly competitive market, characterised by acquisitions, stem mainly from increasing requirements due to government regulations and intensifying competition, e.g. through tenders for health insurers. We know the difficult conditions, products and challenges for supply chains and buyers. You can also draw on our extensive experience from projects with research companies and generic drug manufacturers to secure profit margins.
Healthcare: In the interest of patients and growth
The healthcare system is one of the most important economic sectors in this country today. Suppliers to this sector are also becoming increasingly relevant, as the material share for hospitals takes on a more important role as the second-largest hospital cost item. Especially as hospitals have to pay more attention to costs, it is important that suppliers can offer competitive products. Kloepfel can provide good support here, by mapping the potential and realising the results together with the customer.
Contact persoon
.webp)
Naam
Menno de Goeij
m.degoeij@kloepfel-group.com
Kloepfel's
PVA.
Pharma: Competition starts at procurement
The challenges in the pharmaceutical and biotech industry have been increasing for years due to increasing cost pressure and falling margins. In our country, the high dynamics in this internationally highly competitive market, characterised by acquisitions, stem mainly from increasing requirements due to government regulations and intensifying competition, e.g. through tenders for health insurers. We know the difficult conditions, products and challenges for supply chains and buyers. You can also draw on our extensive experience from projects with research companies and generic drug manufacturers to secure profit margins.
Healthcare: In the interest of patients and growth
The healthcare system is one of the most important economic sectors in this country today. Suppliers to this sector are also becoming increasingly relevant, as the material share for hospitals takes on a more important role as the second-largest hospital cost item. Especially as hospitals have to pay more attention to costs, it is important that suppliers can offer competitive products. Kloepfel can provide good support here, by mapping the potential and realising the results together with the customer.
Gerelateerde
cases.
More information?
Contact us today
